Roche-owned Genentech's KRAS G12C inhibitor, divarasib, has outperformed marketed drugs in its class in a Phase III ...
Morning Overview on MSN
The FDA approved a new drug for thyroid eye disease, a condition that pushes the eyes forward
Patients with thyroid eye disease, a condition that causes the eyes to bulge forward due to swelling behind the eyeball, now ...
Pasqal, through its Canadian subsidiary Aeponyx, today announced the creation of a specialized center of competency focused on assembling and packaging key components used in quantum and advanced ...
This post was created in partnership with EY Studio+ Key takeaways Sports organizations have more data than ever. The ...
27m
Crypto Today: Bitcoin, Ethereum, XRP steady rebound as US and Iran conclude positive talks in Doha
The cryptocurrency market broadly rises on Thursday, reflecting improvement in risk sentiment following an extended period of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results